OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FOR APLASTIC ANEMIA AND ASSOCIATED WITH HIGH RESPONSE RATES
AR Fonsecaa,b, CC Justinoa, VC Mollaa,c, PE Yamakawaa, IB Rabeloa, A Hilld, L Arnoldd, R Kellyd, M Griffind, T Munird, E Vellosoe, T Dalessandroe, AM Risitanof,g, P Scheinbergh, A Kulasekararaji, C Arrais-Rodriguesa,c
a Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
b Hospital Sírio Libanês, São Paulo, Brazil
c Hospital Nove de Julho, São Paulo, Brazil
d Department of Haematology, St James's University Hospital, Leeds, United Kingdom
e Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, Brazil
f Department of Clinical Medicine and Surgery, University of Naples, Naples, Italy
g Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT), Leiden, Netherlands
h Division of Hematology, Hospital A Beneficência Portuguesa, São Paulo, Brazil
i King's College Hospital NHS Foundation Trust, London, United Kingdom
Ver másRead
285
Timeswas read the article
144
Total PDF
141
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 29 | 21 | 50 |
| 2024 April | 33 | 17 | 50 |
| 2024 March | 28 | 21 | 49 |
| 2024 February | 18 | 22 | 40 |
| 2024 January | 7 | 14 | 21 |
| 2023 December | 11 | 18 | 29 |
| 2023 November | 13 | 23 | 36 |
| 2023 October | 2 | 8 | 10 |
